Alphatec boosts full-year revenue guidance to $882 million following strong Q1 surgical volume growth and margin expansion.
Alphatec Holdings (NASDAQ:ATEC) reported Q1 2026 revenue of $192 million, up 14% year-over-year, driven by a 21% increase in surgical case volume. Non-GAAP adjusted EBITDA rose to $21 million, expanding 460 basis points, while free cash flow reached $7 million for the trailing twelve months.
The company secured a new bank facility, cutting annual interest expenses by over $6 million and extending debt maturities to 2031. Alphatec now expects full-year revenue of $882 million, a 15% increase, with surgical revenue projected at $805 million and adjusted EBITDA at $134 million.
Leadership maintained confidence in its procedural ecosystem despite adjusted expectations for its EOS business. The company ended the quarter with $140 million in cash and forecasts at least $20 million in free cash flow for 2026.